D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -10.11M -5.20M -11.39M -10.35M -7.34M
Total Depreciation and Amortization 774.50K 778.30K 785.70K 966.90K 1.06M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.25M -4.44M 2.96M 994.30K -1.70M
Change in Net Operating Assets 942.80K 1.06M -1.88M 2.10M 263.30K
Cash from Operations -7.15M -7.80M -9.53M -6.29M -7.72M
Capital Expenditure -- -- -55.40K -100.30K -52.50K
Sale of Property, Plant, and Equipment 0.00 500.00 -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 5.20M 4.67M 9.39M -1.05M 11.27M
Cash from Investing 5.20M 4.67M 9.33M -1.15M 11.22M
Total Debt Issued -- -- 516.00K -- --
Total Debt Repaid -173.80K -171.90K -274.10K -649.10K -252.30K
Issuance of Common Stock -- -- -- 0.00 0.00
Repurchase of Common Stock 0.00 -2.10K -24.90K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 -25.00K -68.70K
Cash from Financing -173.80K -174.00K 217.00K -674.10K -321.00K
Foreign Exchange rate Adjustments 179.40K 42.50K -288.70K 47.50K 28.30K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -1.95M -3.26M -273.20K -8.07M 3.21M